Scholarly Index
Carol A. Langford
Cleveland Clinic; 16,962 total citations; 283 total publications; best world rank #37
Cleveland Clinic
16,962Total citations
283Total publications
63H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Vasculitis and related conditions | Lifetime | 44 | US 18 | 99.24 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 64 | US 30 | 98.91 |
| Otitis Media and Relapsing Polychondritis | Lifetime | 37 | US 15 | 98.68 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 167 | US 73 | 98.28 |
| Urticaria and Related Conditions | Lifetime | 159 | US 62 | 98.33 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 618 | US 227 | 96.33 |
| Renal Diseases and Glomerulopathies | Lifetime | 925 | US 310 | 96.17 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 789 | US 288 | 87.65 |
| Vascular Anomalies and Treatments | Lifetime | 682 | US 246 | 86.26 |
| Vasculitis and related conditions | 2021-2025 | 39 | US 11 | 98.20 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 330 | US 67 | 87.62 |
| Urticaria and Related Conditions | 2021-2025 | 667 | US 135 | 80.33 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 284 | US 50 | 76.44 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 696 | US 208 | 75.56 |